🇺🇸 FDA
Pipeline program

atosiban

IVFAS1103

Unknown small_molecule completed

Quick answer

atosiban for Repeated Implantation Failure is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Repeated Implantation Failure
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials